Health
New results from a once-promising therapy show the difficulty of treating covid-19 – The Washington Post
The drug, tocilizumab, showed early potential but evidence since then has been conflicting.
But those observations were limited by tiny sizes. One of the first studies to highlight tocilizumabs potential, conducted in February, included only 21 patients. Those results have not been broadly replicated a testament to the difficulty of gauging a treatments effectiveness on the fly when presented with diverse patients at different stages of illness.
Of the trio of new studies, the largest an observational study involving about 4,000 people compared patients who received tocilizumab within…
-
Noosa News23 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News22 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General19 hours agoDairy farmers devastated by floods across parts of New South Wales